DE60134816D1 - Extrakte, Wirkstoffe und pharmazeutische Präparate mit antidiabetischen Eigenschaften und ihre Verwendung - Google Patents
Extrakte, Wirkstoffe und pharmazeutische Präparate mit antidiabetischen Eigenschaften und ihre VerwendungInfo
- Publication number
- DE60134816D1 DE60134816D1 DE60134816T DE60134816T DE60134816D1 DE 60134816 D1 DE60134816 D1 DE 60134816D1 DE 60134816 T DE60134816 T DE 60134816T DE 60134816 T DE60134816 T DE 60134816T DE 60134816 D1 DE60134816 D1 DE 60134816D1
- Authority
- DE
- Germany
- Prior art keywords
- extracts
- active ingredients
- pharmaceutical preparations
- diabetic properties
- diabetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0016213A GB2363985B (en) | 2000-06-30 | 2000-06-30 | Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60134816D1 true DE60134816D1 (de) | 2008-08-28 |
Family
ID=9894853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60134816T Expired - Lifetime DE60134816D1 (de) | 2000-06-30 | 2001-06-14 | Extrakte, Wirkstoffe und pharmazeutische Präparate mit antidiabetischen Eigenschaften und ihre Verwendung |
Country Status (12)
Country | Link |
---|---|
US (2) | US7033616B2 (de) |
EP (1) | EP1166792B1 (de) |
JP (1) | JP2002068994A (de) |
AT (1) | ATE401093T1 (de) |
AU (1) | AU784687B2 (de) |
CA (1) | CA2352005C (de) |
DE (1) | DE60134816D1 (de) |
GB (1) | GB2363985B (de) |
HK (1) | HK1043538A1 (de) |
MX (1) | MXPA01006802A (de) |
NZ (2) | NZ523175A (de) |
ZA (1) | ZA200105278B (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69836321T2 (de) * | 1997-04-15 | 2007-06-28 | Csir, Pretoria | Pflanzenextrakte mit appetitzügelnder Aktivität |
GB2396815B (en) * | 1999-10-27 | 2004-09-08 | Phytopharm Plc | A composition comprising a pregnenone derivative and an NSAID |
GB2363985B (en) * | 2000-06-30 | 2004-09-29 | Phytopharm Plc | Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use |
US20040265398A1 (en) * | 2002-04-25 | 2004-12-30 | Fleischner Albert M. | Herbal composition for weight control |
US7595055B2 (en) | 2003-01-29 | 2009-09-29 | Dal-Hoon Son | Pharmaceutical composition comprising an extract or compounds isolated from Elfvingia applanata for the prevention and the treatment of diabetes and diabetic complications |
WO2004071399A2 (en) * | 2003-02-14 | 2004-08-26 | Phytopharm Plc | Modulation of atp production or content in the hypothalamus |
US7521473B2 (en) | 2004-02-25 | 2009-04-21 | Wyeth | Inhibitors of protein tyrosine phosphatase 1B |
RU2275930C2 (ru) * | 2004-04-26 | 2006-05-10 | ООО "РусГен" | Композиция для коррекции возрастных изменений эндокринной системы человека (варианты) и способ получения фармацевтической формы на основе такой композиции |
US20050276839A1 (en) * | 2004-06-10 | 2005-12-15 | Rifkin Calman H | Appetite satiation and hydration beverage |
US20060083795A1 (en) * | 2004-10-19 | 2006-04-20 | Lima Shatkina | Meal replacement products having appetite suppressing qualities |
GB0425172D0 (en) * | 2004-11-15 | 2004-12-15 | Phyto Res Ltd | Plant cells and uses thereof |
GB0428515D0 (en) * | 2004-12-30 | 2005-02-09 | Unilever Plc | Edible compositions and their preparation |
US8173437B2 (en) * | 2005-06-10 | 2012-05-08 | Mannatech, Incorporated | Rapid serum sugar biomarker assay of rheumatoid arthritis |
US8945652B2 (en) | 2005-11-23 | 2015-02-03 | The Coca-Cola Company | High-potency sweetener for weight management and compositions sweetened therewith |
WO2007094497A1 (ja) * | 2006-02-17 | 2007-08-23 | Use-Techno Corporation | メタボリックシンドローム改善剤 |
US20070207227A1 (en) * | 2006-02-23 | 2007-09-06 | Conopco, Inc., D/B/A Unilever, A Corporation Of New York | Appetite suppressant compositions |
AU2007260087B2 (en) * | 2006-06-13 | 2011-02-10 | Phytopharm Plc | Unit serving appetite suppressant compositions with steroidal glycosides |
JP5281234B2 (ja) * | 2006-06-27 | 2013-09-04 | ポーラ化成工業株式会社 | 毛様体過緊張による疲れ目の改善・予防のための経口投与組成物 |
MX2009001571A (es) * | 2006-08-17 | 2009-02-19 | Unilever Nv | Proceso para la produccion de la planta de hoodia que contiene glucosidos esteroides. |
US20080138447A1 (en) * | 2006-12-06 | 2008-06-12 | Erin John Riggins | Method for administering appetite suppressant and composition thereof |
AU2007336412A1 (en) * | 2006-12-21 | 2008-06-26 | Unilever Plc | Process for harvesting plants of the Apocynaceae family |
EP2080517A1 (de) * | 2008-01-18 | 2009-07-22 | Unilever N.V. | Verfahren zur Gewinnung trockenen Pflanzenmaterials |
US7923435B2 (en) | 2008-04-21 | 2011-04-12 | Phytopharm Plc | Hoodia plant extract with improved flavor |
US20090263510A1 (en) | 2008-04-21 | 2009-10-22 | Conopco, Inc., D/B/A Unilever | Process of making Hoodia plant extract with improved flavor |
EP2373324A1 (de) * | 2008-12-08 | 2011-10-12 | Hadasit Medical Research Services & Development Limited | Verfahren zur behandlung von erkrankungen mit hoodia-extrakten |
EP2329836A1 (de) | 2009-12-03 | 2011-06-08 | I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. | Extrakte aus Hoodia gordonii-Zelllinien, deren Herstellung und Verwendung |
WO2012022880A2 (fr) | 2010-07-29 | 2012-02-23 | Universite De Strasbourg | Procede de synthese de steroïdes |
Family Cites Families (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4199A (en) | 1845-09-19 | sickels | ||
US648967A (en) * | 1899-07-15 | 1900-05-08 | Landon M Littlefield | Corn and pea planter. |
US4062950A (en) | 1973-09-22 | 1977-12-13 | Bayer Aktiengesellschaft | Amino sugar derivatives |
FR2348655A1 (fr) * | 1976-04-20 | 1977-11-18 | Sopharga Lab | Nouvelle substance alimentaire ou dietetique ayant une structure alveolaire et son procede de preparation |
US4185116A (en) * | 1976-09-28 | 1980-01-22 | Pfizer Inc. | L- and DL- Phenylglycines to treat diseases or conditions attributable to reduced carbohydrate metabolism |
DE2719912C3 (de) | 1977-05-04 | 1979-12-06 | Bayer Ag, 5090 Leverkusen | Verfahren zur Isolierung von 0- |4,6-Dideoxy-4- [JJl S-O,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a -D-glucopyranosyl} -(I Pfeil nach rechts 4)-0- a D-glucopyranosyl-(l Pfeil nach rechts 4)-D-glucopyranose aus Kulturbrühen |
US4130714A (en) | 1977-05-23 | 1978-12-19 | Pfizer Inc. | Hydantoin therapeutic agents |
NO154918C (no) | 1977-08-27 | 1987-01-14 | Bayer Ag | Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin. |
JPS5953920B2 (ja) | 1977-12-28 | 1984-12-27 | 東洋醸造株式会社 | 新規なアミノ糖化合物およびその製法 |
IE47592B1 (en) | 1977-12-29 | 1984-05-02 | Ici Ltd | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture |
US4273763A (en) * | 1978-01-23 | 1981-06-16 | Efamol Limited | Pharmaceutical and dietary compositions |
JPS5745185A (en) | 1980-07-21 | 1982-03-13 | Eisai Co Ltd | Hydantoin derivative and its preparation |
US4791126A (en) | 1980-08-22 | 1988-12-13 | Ono Pharmaceutical Co., Ltd. | Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredients |
JPS5740478A (en) | 1980-08-22 | 1982-03-06 | Ono Pharmaceut Co Ltd | Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative |
DE3166093D1 (en) | 1981-01-05 | 1984-10-18 | Takeda Chemical Industries Ltd | N-substituted pseudo-aminosugars, their production and use |
CA1176269A (en) | 1981-03-02 | 1984-10-16 | Kazimir Sestanj | N-naphthoylglycine derivatives |
US4377500A (en) | 1981-07-08 | 1983-03-22 | The Standard Oil Co. | Catalysts |
US4438272A (en) | 1982-04-15 | 1984-03-20 | Alcon Laboratories, Inc. | Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones |
US4436745A (en) | 1982-04-15 | 1984-03-13 | Alcon Laboratories, Inc. | Method of inhibiting aldose reductase activity |
US4883880A (en) * | 1982-05-03 | 1989-11-28 | Agfa-Gevaert Aktiengessellschaft | Process for the preparation of sulfoalkyl quaternary salts and for the production of alkane sultones |
JPS58194818A (ja) | 1982-05-10 | 1983-11-12 | Iwasaki Shuzo | サボテン中の水溶性多糖及び繊維の取得方法 |
ES524614A0 (es) * | 1982-08-12 | 1984-05-01 | Nativelle Sa Ets | Procedimiento de preparacion de nuevos amino-14 esteroides. |
AU570439B2 (en) | 1983-03-28 | 1988-03-17 | Compression Labs, Inc. | A combined intraframe and interframe transform coding system |
HU201675B (en) | 1983-08-26 | 1990-12-28 | Ivan Balkanyi | Process for producing oral pharmaceutical compositions with unappetizing effect |
US5066659A (en) | 1984-10-30 | 1991-11-19 | Pfizer Inc. | Spiro-heteroazalones for treatment of diabetic complications |
US4634765A (en) | 1984-12-18 | 1987-01-06 | Merrell Dow Pharmaceuticals Inc. | Homodisaccharide hypoglycemic agents |
US5246960A (en) * | 1984-12-21 | 1993-09-21 | Hoffmann-La Roche Inc. | Oxetanones |
CA1270837A (en) * | 1984-12-21 | 1990-06-26 | Hoffmann-La Roche Limited | Oxetanones |
IT1207504B (it) | 1985-09-26 | 1989-05-25 | Crinos Industria Farmaco | Composizione moderatrice dell'appetito ed antigastrica. |
IT1190400B (it) | 1985-10-04 | 1988-02-16 | Istituto Biochimico Italiano | Derivati dell'acido 19,20-bis,nor-prostanoico ad attivita' antiulcera e anoressivca,procedimento per la loro preparazione e composizioni farmaceutiche |
GB8524663D0 (en) | 1985-10-07 | 1985-11-13 | Fujisawa Pharmaceutical Co | Quinazoline derivatives |
US4939140A (en) | 1985-11-07 | 1990-07-03 | Pfizer Inc. | Heterocyclic oxophthalazinyl acetic acids |
US4757151A (en) | 1985-11-14 | 1988-07-12 | Warner-Lambert Company | 2-substituted-[2-substituted-amino]-N-arylalkyl-3-[indol-3-yl] |
US4652553A (en) * | 1985-11-25 | 1987-03-24 | Merck & Co., Inc. | Steroidal glycolipids as host resistance stimulators |
GB8600489D0 (en) * | 1986-01-09 | 1986-02-12 | Erba Farmitalia | Aminoglycoside steroids |
AU602641B2 (en) | 1986-04-17 | 1990-10-18 | Senju Pharmaceutical Co., Ltd. | Thiolactam-N-acetic acid derivatives, their production and use |
DE3769066D1 (de) | 1986-08-28 | 1991-05-08 | Sanwa Kagaku Kenkyusho Co | Hydantoin-derivate zur behandlung von komplikationen bei diabetes. |
ZA883929B (en) | 1987-06-22 | 1990-02-28 | Hoffmann La Roche | Cholecystokinin analogs for controlling appetite |
US5175154A (en) * | 1987-11-25 | 1992-12-29 | Research Corporation Technologies, Inc. | 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds |
US5192772A (en) | 1987-12-09 | 1993-03-09 | Nippon Shinyaku Co. Ltd. | Therapeutic agents |
GB8801037D0 (en) * | 1988-01-18 | 1988-02-17 | Plessey Co Ltd | Improvements relating to fuel supply systems |
US5252572A (en) | 1988-02-03 | 1993-10-12 | Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt. | Pyridopyrimidine derivatives, pharmaceutical compositions containing them and process for preparing same |
EP0344383A1 (de) | 1988-06-02 | 1989-12-06 | Merrell Dow Pharmaceuticals Inc. | Alpha-Glucosidase-Inhibitoren |
DE3836675A1 (de) | 1988-10-28 | 1990-05-03 | Hoechst Ag | Glykosidase-inhibitor salbostatin, verfahren zu seiner herstellung und seine verwendung |
US4978669A (en) | 1989-06-08 | 1990-12-18 | Neurex Corporation | Method of suppressing appetite by administration of tetrahydro-beta-carboline derivatives |
JPH03120227A (ja) * | 1989-10-02 | 1991-05-22 | Shigeo Ochi | 飲食物消化分解産物吸収抑制剤 |
US4980357A (en) | 1990-03-01 | 1990-12-25 | Pfizer Inc. | Azolidinedione derivatives |
US5037831A (en) | 1990-05-21 | 1991-08-06 | American Home Products Corporation | Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors |
US5504078A (en) | 1990-06-08 | 1996-04-02 | Merrell Dow Pharmaceuticals Inc. | α-glucosidase inhibitors |
GB9016978D0 (en) | 1990-08-02 | 1990-09-19 | Ici Plc | Acetamide derivatives |
US5091418A (en) | 1990-09-28 | 1992-02-25 | Bristol-Myers Squibb Company | Novel alpha-glucosidase inhibitor, pradimicin Q |
US5217877A (en) | 1990-09-28 | 1993-06-08 | Bristol-Myers Squibb Company | Process for the preparation of α-glucosidase inhibitor, pradimicin Q |
US6100048A (en) | 1992-04-10 | 2000-08-08 | Oregon Health Sciences University | Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals |
WO1994007867A1 (en) | 1992-09-28 | 1994-04-14 | Pfizer Inc. | Substituted pyrimidines for control of diabetic complications |
BR9307148A (pt) | 1992-09-30 | 1999-03-30 | Motorola Inc | Processo em sistema de comunicação para enviar mensagens confiavelmente receptor de chamada seletivo portátil sistema de comunicação para enviar mensagens confiavelmente em pelo menos um receptor de comunicação processo em sistema de comunicação para enviar mensagens confiavelmente em receptor de chamada seletivo e sistema de comunicação de correio eletrônico |
GB9307833D0 (en) | 1993-04-15 | 1993-06-02 | Glaxo Inc | Modulators of cholecystokinin and gastrin |
FR2706255B1 (fr) | 1993-06-17 | 1995-10-27 | Univ Rennes | Composition à usage alimentaire et/ou pharmaceutique pauvre en polyamines et applications thérapeutiques. |
WO1995000161A1 (en) | 1993-06-18 | 1995-01-05 | University Of Cincinnati | Neuropeptide y antagonists and agonists |
US5516516A (en) * | 1993-10-19 | 1996-05-14 | Cherksey; Bruce D. | Method of preparing muira puama extract and its use for decreasing body fat percentage and increasing lean muscle mass |
JPH07184548A (ja) * | 1993-12-28 | 1995-07-25 | Meiji Seito Kk | 口腔用組成物 |
US6309853B1 (en) * | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
ZA96626B (en) | 1995-02-09 | 1996-08-15 | Sastech Pty Ltd | Copolymerization |
US5698199A (en) * | 1995-03-10 | 1997-12-16 | Kao Corporation | Lipolysis acceleration method |
WO1996039385A1 (en) | 1995-06-06 | 1996-12-12 | Pfizer Inc. | Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors |
MX9709875A (es) | 1995-06-06 | 1998-03-31 | Pfizer | N-(indol-2-carbonil)-glicinamidas substituidas y derivados como inhibidores de glicogeno fosforilasa, composiciones que las contienen y uso de las mismas. |
US5693327A (en) * | 1995-07-12 | 1997-12-02 | Shah; Eladevi | Herbal compositions |
CA2238940A1 (en) | 1995-10-26 | 1997-05-01 | Board Of Regents, The University Of Texas System | Luminal cholecystokinin-releasing factor |
US5824668A (en) * | 1996-11-07 | 1998-10-20 | Supergen, Inc. | Formulation for administration of steroid compounds |
TW432073B (en) | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
WO1997031943A1 (en) | 1996-03-01 | 1997-09-04 | Novo Nordisk A/S | Use of a pharmaceutical composition comprising an appetite-suppressing peptide |
US5908609A (en) * | 1996-06-10 | 1999-06-01 | Millennium Pharmaceuticals, Inc. | Screening methods for compounds useful in the regulation of body weight |
US5932779A (en) | 1996-06-10 | 1999-08-03 | Millennium Pharmaceuticals, Inc. | Screening methods for compounds useful in the regulation of body weight |
EP0942967A1 (de) | 1996-11-06 | 1999-09-22 | Children's Medical Center Corporation | Transgene-tier, das einen syndecan in den gebieten des hypothalamus exprimiert |
CA2275442A1 (en) | 1996-12-17 | 1998-06-25 | Quadrant Holdings Cambridge Limited | Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5 |
CA2217698A1 (en) | 1996-12-20 | 1998-06-20 | Eli Lilly And Company | Anti-obesity proteins |
US5798101A (en) * | 1997-01-22 | 1998-08-25 | Hpf, L.L.C. | Herbal appetite suppressant and weight loss composition |
JP2002538757A (ja) | 1997-03-26 | 2002-11-12 | ノボ ノルディスク アクティーゼルスカブ | 食欲制御活性を有するポリペプチド |
DE69836321T2 (de) * | 1997-04-15 | 2007-06-28 | Csir, Pretoria | Pflanzenextrakte mit appetitzügelnder Aktivität |
FR2771105A1 (fr) * | 1997-11-20 | 1999-05-21 | Vitasterol | Utilisation du fusarium monoliforme pour la preparation des derives 7alpha-hydroxyles de la dehydroepiandrosterone et de la pregnenolone |
HUP9803039A2 (hu) | 1998-12-30 | 2000-09-28 | István Lelkes | Az elhízás kezelésére, megelőzésére, szövődményei kialakulásának kivédésére, a kialakult szövődmények kezelésére szolgáló gyógyászati kompozíció |
GB2396815B (en) * | 1999-10-27 | 2004-09-08 | Phytopharm Plc | A composition comprising a pregnenone derivative and an NSAID |
GB2363985B (en) | 2000-06-30 | 2004-09-29 | Phytopharm Plc | Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use |
-
2000
- 2000-06-30 GB GB0016213A patent/GB2363985B/en not_active Expired - Fee Related
-
2001
- 2001-06-14 EP EP01305172A patent/EP1166792B1/de not_active Revoked
- 2001-06-14 AT AT01305172T patent/ATE401093T1/de not_active IP Right Cessation
- 2001-06-14 DE DE60134816T patent/DE60134816D1/de not_active Expired - Lifetime
- 2001-06-20 NZ NZ523175A patent/NZ523175A/en unknown
- 2001-06-20 NZ NZ512505A patent/NZ512505A/en unknown
- 2001-06-26 ZA ZA200105278A patent/ZA200105278B/xx unknown
- 2001-06-27 US US09/891,615 patent/US7033616B2/en not_active Expired - Fee Related
- 2001-06-27 AU AU54078/01A patent/AU784687B2/en not_active Ceased
- 2001-06-27 CA CA2352005A patent/CA2352005C/en not_active Expired - Fee Related
- 2001-07-02 MX MXPA01006802A patent/MXPA01006802A/es active IP Right Grant
- 2001-07-02 JP JP2001201355A patent/JP2002068994A/ja not_active Withdrawn
-
2002
- 2002-05-27 HK HK02103916.3A patent/HK1043538A1/zh unknown
-
2005
- 2005-10-13 US US11/248,614 patent/US7416744B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
HK1043538A1 (zh) | 2002-09-20 |
CA2352005A1 (en) | 2001-12-30 |
AU784687B2 (en) | 2006-06-01 |
JP2002068994A (ja) | 2002-03-08 |
AU5407801A (en) | 2002-01-03 |
US20020146468A1 (en) | 2002-10-10 |
GB2363985A (en) | 2002-01-16 |
ATE401093T1 (de) | 2008-08-15 |
US7033616B2 (en) | 2006-04-25 |
EP1166792A3 (de) | 2003-03-05 |
US7416744B2 (en) | 2008-08-26 |
CA2352005C (en) | 2011-01-04 |
NZ523175A (en) | 2005-04-29 |
GB2363985B (en) | 2004-09-29 |
US20060159779A1 (en) | 2006-07-20 |
EP1166792A2 (de) | 2002-01-02 |
MXPA01006802A (es) | 2003-08-20 |
NZ512505A (en) | 2003-05-30 |
GB0016213D0 (en) | 2000-08-23 |
EP1166792B1 (de) | 2008-07-16 |
ZA200105278B (en) | 2002-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60134816D1 (de) | Extrakte, Wirkstoffe und pharmazeutische Präparate mit antidiabetischen Eigenschaften und ihre Verwendung | |
HUP0000838A2 (hu) | Szteroid-glikozidot tartalmazó extraktum, eljárás izolálására és szintetikus előállítására, valamint ezt tartalmazó étvágycsökkentő gyógyszerkészítmények | |
HUP0104718A2 (hu) | Mikronizált eplerenon kompozíciók és eljárás az előállításukra | |
MY115339A (en) | Compositions containing micronized nebivolol | |
BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
ATE329608T1 (de) | Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung | |
HUP0100178A2 (hu) | Tetrahidro-naftiridinil-imidazolidinil-karbonsav-származékok és ezeket tartalmazó gyógyszerkészítmények | |
ATE246497T1 (de) | Fluorchlorkohlenwasserstoffreie aerosolformulierungen | |
EA200400730A1 (ru) | Ингалятор контролируемой дозы | |
MXPA04004842A (es) | Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1. | |
BR9810495A (pt) | Composição farmacêutica | |
BR0212075A (pt) | Combinações de substâncias ativas fungicidas | |
ATE137958T1 (de) | Pharmazeutische aerosolzubereitung sowie deren verwendung zur behandlung und prophylaxe viraler erkrankungen | |
HUP9801128A2 (hu) | Fukopeptidek, eljárás azok előállítására és alkalmazására, valamint ilyen vegyületeket tartalmazó gyógyszerkészítmények | |
WO2005065639A3 (en) | Novel pharmaceutical compositions | |
DE59401618D1 (de) | Präparate aus crataegus-arten, arzneimittel und ihre verwendung zur verhinderung des plötzlichen herztodes sowie von reperfusions-bedingten cardiovaskulären schädigungen | |
CA2340734A1 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases | |
WO2002062952A3 (en) | Non-cytotoxic pap mutants | |
ITRM910430A1 (it) | Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego | |
RS44304A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
FR2673375B1 (de) | ||
DE69927260D1 (de) | Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis | |
DE69805860D1 (de) | Wasserlösliche ähnliche verbindungen und medicament-vorstufe von paclitaxel | |
TR199900523T2 (xx) | Vir�s k�kenli hastal�klar�n tedavisi i�in farmas�tik bile�imler. | |
JP2002020308A5 (de) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8328 | Change in the person/name/address of the agent |
Representative=s name: MEISSNER, BOLTE & PARTNER GBR, 80538 MUENCHEN |
|
8327 | Change in the person/name/address of the patent owner |
Owner name: PHYTOPHARM PLC, GODMANCHESTER, CAMBRIDGESHIRE, GB |
|
8363 | Opposition against the patent |